Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamune for secondary prevention of skin cancers in renal transplant recipients
2005-004509-27Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sirolimus in cutaneous squamous cell carcinoma (cSCC) (2 arms), sponsored by CHU de Nantes. Primary endpoint: Annual incidence of cutaneous squamous cell carcinoma. Started Feb 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on 2005-004509-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004509-27.